A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is compare the relative bioavailability of 500 mg Metformin
Hydrochloride Extended Release Tablets by Alpharma with that of 500 mg CLUCOPHAGE® XR Tablets
distributed by Bristol-Myers Squibb Company following a single oral dose (1 x 500 mg
extended-release tablet) in healthy adult volunteers under fasting conditions.